The Japan Peripheral Vascular Devices Market was valued at $157.54 Million in 2026 and projected to reach to $229.56 Million by 2031, representing a compound annual growth rate of 7.8%. Japan's peripheral vascular devices market is positioned for substantial growth, driven by demographic shifts and rising cardiovascular disease prevalence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases the prevalence of peripheral arterial disease and vascular conditions, creating sustained demand for peripheral vascular devices.
Japan's advanced healthcare system and high healthcare spending per capita enable rapid adoption of innovative vascular intervention technologies and cutting-edge peripheral vascular device solutions.
The market is projected to grow from USD 157.54 million in 2026 to USD 229.56 million by 2031, with a CAGR of 7.8%, outpacing the global growth rate of 5.7%.
Increasing incidence of diabetes, hypertension, and lifestyle-related vascular diseases in Japan is accelerating the need for advanced peripheral vascular intervention devices and treatment options.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | HEMODYNAMIC FLOW ALTERATION DEVICES (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 5.7% from 2026 to 2031 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 10.02 (2026) |
| Revenue Forecast (Billions) | ~USD 13.22 (2031) |
| Segments Covered | Type, Delivery Platform, End User, Product Type |
4 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS | 75.2 | 78.2 | 83.8 | 90.3 | 97.5 | 105.3 | 113.9 | 123.4 | 8 |
| HOSPITALS | 462.6 | 484.7 | 523.4 | 568.1 | 617.5 | 672.3 | 732.2 | 799 | 8.8 |
| OTHER END USERS | 41.1 | 42.4 | 45.1 | 48.2 | 51.5 | 55.2 | 59.2 | 63.6 | 7.1 |
| TOTAL | 578.9 | 605.3 | 652.3 | 706.6 | 766.4 | 832.8 | 905.2 | 985.9 | 8.6 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| STENTYS | France | Private Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| NOLATO | Sweden | Public Company | Angioplasty Balloon & Angioplasty Stent (components and subassemblies),Catheters (IVUS/OCT and diagnostic/guide catheters components),Plaque Modification (atherectomy and specialty balloon components), |
| SANOFI | France | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| CONMED CORPORATION | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT and Peripheral Access/Intervention),Plaque Modification Devices, |
| ABBOTT LABORATORIES | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| CARDINAL HEALTH, INC. | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT and diagnostic/guide),Plaque Modification Devices, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Catheters (IVUS/OCT),Plaque Modification,Angioplasty Balloon & Angioplasty Stent, |
| TERUMO CORPORATION | Japan | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Vascular Closure Devices, |
| MERIT MEDICAL SYSTEMS, INC. | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT and other peripheral catheters),Plaque Modification, |
| MEDTRONIC | Ireland | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| PENUMBRA, INC. | United States | Public Company | Catheters (IVUS/OCT and aspiration/access catheters),Plaque Modification,Angioplasty Balloon & Angioplasty Stent, |
| STRYKER CORPORATION | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| CORDIS | United States | Private Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| COOK | United States | Public Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
| BIOSENSORS INTERNATIONAL GROUP, LTD. | Singapore | Private Company | Angioplasty Balloon & Angioplasty Stent,Catheters (IVUS/OCT),Plaque Modification, |
STENTYS is a French private company founded in 2006 that employs 26 people. The company operates in the medical device sector.
NOLATO is a Swedish public company founded in 1938 with 5,607 employees. The company is a major player in polymer-based solutions and medical devices.
SANOFI is a French public pharmaceutical company founded in 1994 with 74,846 employees. The company is a global leader in healthcare and pharmaceutical products.
CONMED CORPORATION is a United States public company founded in 1970 with 3,900 employees. The company specializes in medical technology and surgical equipment.
BOSTON SCIENTIFIC CORPORATION is a United States public company founded in 1979 with 59,000 employees. The company is a leading manufacturer of medical devices and equipment.
BECTON, DICKINSON AND COMPANY is a United States public company founded in 1897 with 72,000 employees. The company is a global medical technology manufacturer specializing in diagnostics and drug delivery.
ABBOTT LABORATORIES is a United States public company founded in 1888 with 115,000 employees. The company is a diversified healthcare company with operations in pharmaceuticals, diagnostics, and medical devices.
CARDINAL HEALTH, INC. is a United States public company founded in 1979 with 55,392 employees. The company is a leading healthcare services and products distributor.
KONINKLIJKE PHILIPS N.V. is a Netherlands public company founded in 1891 with 64,317 employees. The company is a global leader in health technology and electronics.
TERUMO CORPORATION is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures medical devices and blood management solutions.
MERIT MEDICAL SYSTEMS, INC. is a United States public company founded in 1987 with 7,500 employees. The company develops and manufactures minimally invasive medical devices.
MEDTRONIC is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.
PENUMBRA, INC. is a United States public company founded in 2004 with 4,700 employees. The company specializes in minimally invasive medical devices for vascular and neurovascular interventions.
STRYKER CORPORATION is a United States public company founded in 1941 with 56,000 employees. The company is a leading manufacturer of medical devices and surgical equipment.
CORDIS is a United States private company founded in 1957 with 3,620 employees. The company manufactures cardiovascular and endovascular medical devices.
COOK is a United States public company founded in 1987 with 433 employees. The company operates in the medical device industry.
BIOSENSORS INTERNATIONAL GROUP, LTD. is a Singapore private company founded in 1990 with 312 employees. The company develops and manufactures cardiovascular medical devices.
Japan's peripheral vascular devices market is estimated at USD 157.54 million in 2026.
Japan's peripheral vascular devices market is forecast to reach USD 229.56 million by 2031.
Japan's peripheral vascular devices market is expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2031.
Japan's market growth is driven by an aging population, rising prevalence of peripheral arterial disease, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies.
Japan's 7.8% CAGR outpaces the global market CAGR of 5.7%, reflecting stronger regional demand and demographic tailwinds specific to Japan.
This study involved four major activities in estimating the size of the peripheral vascular devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the peripheral vascular devices market. The information was used to identify key players in the market and to classify and segment it at a detailed level, in line with industry trends. Additionally, important developments related to market and technology perspectives were noted. A database of the leading industry figures was created through secondary research.
Extensive primary research was conducted after obtaining secondary research on the peripheral vascular devices market. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included a range of industry experts, such as Chief X Officers (CXOs), vice presidents (VPs), directors from business development, marketing, and product development or innovation teams, along with other key executives from manufacturers and distributors operating in the peripheral vascular devices market, as well as key opinion leaders.
Primary interviews were conducted to gather insights into market statistics, revenue from products and services, market breakdowns, market size estimates, market forecasting, and data triangulation. Primary research also helped in understanding the various trends in technology, applications, verticals, and regions. Stakeholders from the demand side were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage, and the future outlook of their business, which will affect the overall market.
The following is a breakdown of the primary respondents:

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the peripheral vascular devices market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the peripheral vascular devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall peripheral vascular devices market was obtained from secondary data and validated by primary participants to arrive at the total peripheral vascular devices market. Primary participants further validated the numbers.
Geographic Market Assessment (by Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall peripheral vascular devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Peripheral Vascular Devices Market Size: Top-down and Bottom-up Approach

The market was split into several segments and subsegments after determining the overall market size, using the market sizing processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine the exact statistics for each market segment and subsegment. The data was triangulated by examining various factors and trends on both the demand and supply sides of the peripheral vascular devices market.
Peripheral vascular devices are medical equipment and instruments used to diagnose, treat, or manage peripheral vascular diseases in patients. It pertains to diseases or disorders involving the arteries, veins, and lymphatic vessels outside the heart and brain. The overall application of peripheral vascular devices is to treat PAD, DVT, and other vascular disorders. It facilitates procedures that are intended to restore normal blood flow, remove clots, and keep the vessel open. Examples include balloon catheters, stents, guidewires, atherectomy devices, and vascular grafts.
Full forecast, segment splits, and company analysis for all Peripheral Vascular Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report